Pergamon-Elsevier Science Ltd

SHERPA: Unknown

People

  1. Danishefsky
    Danishefsky
  2. Chiosis
    Chiosis
  3. Rosen
    Rosen
  4. Motzer
    Motzer
  5. Scheinberg
    Scheinberg
  6. Tan
    Tan
  7. Taldone
    Taldone
  8. Ouerfelli
    Ouerfelli
  9. Solit
    Solit
  10. Hudis
    Hudis

Groups

  1. Sloan Kettering Institute Faculty (143)
  2. Molecular Pharmacology and Chemistry Program Faculty (139)
  3. Department of Medicine (75)
  4. GSK Faculty (63)
  5. Solid Tumor Oncology Division (52)
  6. Center for Hematologic Malignancies (32)
  7. Sloan Kettering Institute Postdocs (30)
  8. Hematologic Malignancies Research (25)
  9. Breast Medicine Service (24)
  10. Center for Molecular Imaging and Biotechnology (CMIB) (22)
Search Within
Formats
  1. Journal Article (219)
  2. Meeting Abstract (87)
  3. Book Section (7)
  4. Book Whole (2)
  5. Research Letter (2)
  6. Review (2)
  7. Conference Paper (1)
  8. Editorial (1)
Groups
  1. Sloan Kettering Institute Faculty (143)
  2. Molecular Pharmacology and Chemistry Program Faculty (139)
  3. Department of Medicine (75)
  4. GSK Faculty (63)
  5. Solid Tumor Oncology Division (52)
  6. Center for Hematologic Malignancies (32)

More Groups

People
  1. Samuel Danishefsky (73)
  2. Gavril Pasternak (19)
  3. Gabriela Chiosis (16)
  4. Ting-Chao Chou (16)
  5. Huajin Dong (10)
  6. Neal Rosen (10)

More People

Years
  1. 2025 (1)
  2. 2024 (8)
  3. 2023 (3)
  4. 2022 (1)
  5. 2021 (1)
  6. 2020 (4)

More Years

Publications
  1. EJC Supplements (82)
  2. Tetrahedron Letters (75)
  3. Bioorganic & Medicinal Chemistry Letters (28)
  4. Bioorganic & Medicinal Chemistry (24)
  5. Molecular Immunology (20)
  6. Neuropharmacology (15)

More Publications

Results (321)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Economic evaluation of sunitinib vs. interferon-alfa (IFN-alpha) in first-line metastatic renal cell carcinoma (mRCC)
    Meeting Abstract

    Negrier, S.; Remak, E.; Brown, R.; Kim, S. T.; Charbonneau, C.; Motzer, R. J.
    EJC Supplements (2007)

    Fulltext@MSK | Save
  • Sunitinib versus interferon (IFN)-alfa as first-line treatment of metastatic renal cell carcinoma (mRCC): Updated efficacy and safety results and further analysis of prognostic factors
    Meeting Abstract

    Motzer, R. J.; Michaelson, M. D.; Hutson, T. E.; Tomczak, P.; Bukowski, R. M.; Rixe, O.; Negrier, S.; Kim, S. T.; Chen, I.; Figlin, R. A.
    EJC Supplements (2007)

    Fulltext@MSK | Save
  • Biomarkers of brain tumors to EGFR-TKI
    Meeting Abstract

    Mellinghoff, I.
    EJC Supplements (2007)

    Fulltext@MSK | Save
  • Chemotherapy in elderly patients with renal insufficiency. Recommendations of the International Society of Geriatric Oncology (SIOG)
    Meeting Abstract

    Lichtman, S. M.; Wildiers, H.; Launay-Vacher, V.; Steer, C.; Chatelut, E.; Aapro, M.
    EJC Supplements (2007)

    Fulltext@MSK | Save
  • Renal insufficiency in elderly cancer patients: International Society of Geriatric Oncology (SIOG) clinical practice recommendations
    Meeting Abstract

    Launay-Vacher, V.; Chatelut, E.; Lichtman, S. M.; Wildiers, H.; Steer, C.; Aapro, M.
    EJC Supplements (2007)

    Fulltext@MSK | Save
  • A phase I study of trastuzumab-DM1, a first-in-class HER2 antibody-drug conjugate, in patients with HER2+metastatic breast cancer
    Meeting Abstract

    Krop, I. E.; Beeram, M.; Modi, S.; Rabbee, N.; Girish, S.; Tibbitts, J.; Holden, S. N.; Lutzker, S. G.; Burris, H. A.
    EJC Supplements (2007)

    Fulltext@MSK | Save
  • Sunitinib plus interferon-alfa in the first-line treatment for metastatic renal cell carcinoma (mRCC): Results of a dose-finding study
    Meeting Abstract

    Kondagunta, G. V.; Hudes, G.; Figlin, R.; Wilding, G.; Hariharan, S.; Kempin, S.; Fayyad, R.; Hoosen, S.; Motzer, R. J.
    EJC Supplements (2007)

    Fulltext@MSK | Save
  • Personalized therapy with trabectedin (Yondelis (R)) in advanced pre-treated sarcomas
    Meeting Abstract

    Jimeno, J.; Schoeffski, P.; Casali, P.; Grosso, F.; Judson, I.; Scurr, M.; Blay, J. Y.; Maki, R.; LeCasne, A.; Rosell, R.
    EJC Supplements (2007)

    Fulltext@MSK | Save
  • A population pharmacokinetic/pharmacodynamic (PK/PD) analysis of exposure-response for sunitinib in metastatic renal cell carcinoma (mRCC)
    Meeting Abstract

    Houk, B. E.; Bello, C. L.; Michaelson, M. D.; Bukowski, R. M.; Redman, B.; Hudes, G. R.; Wilding, G.; Motzer, R. J.
    EJC Supplements (2007)

    Fulltext@MSK | Save
  • Sunitinib in patients with cytokine-refiractory metastatic renal cell carcinoma (mRCC)
    Meeting Abstract

    George, D. J.; Michaelson, M. D.; Rosenberg, J. E.; Redman, B. G.; Hudes, G. R.; Bukowski, R. M.; Kim, S. T.; Chen, I.; Wilding, G.; Motzer, R. J.
    EJC Supplements (2007)

    Fulltext@MSK | Save